Ho SM - Search Results

1

Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.

Xiong SD, Yu K, Liu XH, Yin LH, Kirschenbaum A, Yao S, Narla G, DiFeo A, Wu JB, Yuan Y, Ho SM, Lam YW, Levine AC. Xiong SD, et al. Among authors: ho sm. Int J Cancer. 2009 Aug 15;125(4):774-82. doi: 10.1002/ijc.24325. Int J Cancer. 2009. PMID: 19384952 Free PMC article.

2

Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.

Lam YW, Mobley JA, Evans JE, Carmody JF, Ho SM. Lam YW, et al. Among authors: ho sm. Proteomics. 2005 Jul;5(11):2927-38. doi: 10.1002/pmic.200401165. Proteomics. 2005. PMID: 15952230

3

Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.

Lam YW, Yuan Y, Isaac J, Babu CV, Meller J, Ho SM. Lam YW, et al. Among authors: ho sm. PLoS One. 2010 Feb 5;5(2):e9075. doi: 10.1371/journal.pone.0009075. PLoS One. 2010. PMID: 20140087 Free PMC article.

4

Differential proteomics in the aging Noble rat ventral prostate.

Lam YW, Tam NN, Evans JE, Green KM, Zhang X, Ho SM. Lam YW, et al. Among authors: ho sm. Proteomics. 2008 Jul;8(13):2750-63. doi: 10.1002/pmic.200700986. Proteomics. 2008. PMID: 18546156 Free PMC article.

5

Monitoring the serological proteome: the latest modality in prostate cancer detection.

Mobley JA, Lam YW, Lau KM, Pais VM, L'Esperance JO, Steadman B, Fuster LM, Blute RD, Taplin ME, Ho SM. Mobley JA, et al. Among authors: ho sm. J Urol. 2004 Jul;172(1):331-7. doi: 10.1097/01.ju.0000132355.97888.50. J Urol. 2004. PMID: 15201806

6

Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion.

Lam HM, Suresh Babu CV, Wang J, Yuan Y, Lam YW, Ho SM, Leung YK. Lam HM, et al. Among authors: ho sm. Mol Cell Endocrinol. 2012 Jul 6;358(1):27-35. doi: 10.1016/j.mce.2012.02.012. Epub 2012 Feb 19. Mol Cell Endocrinol. 2012. PMID: 22370157 Free PMC article.

7

Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.

Ho SM, Yu M. Ho SM, et al. Cancer Res. 1993 Feb 1;53(3):528-32. Cancer Res. 1993. PMID: 7678774

8

Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

Lau KM, LaSpina M, Long J, Ho SM. Lau KM, et al. Among authors: ho sm. Cancer Res. 2000 Jun 15;60(12):3175-82. Cancer Res. 2000. PMID: 10866308

9

Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.

Lam HM, Ouyang B, Chen J, Ying J, Wang J, Wu CL, Jia L, Medvedovic M, Vessella RL, Ho SM. Lam HM, et al. Among authors: ho sm. Endocr Relat Cancer. 2014;21(6):903-14. doi: 10.1530/ERC-14-0402. Epub 2014 Oct 6. Endocr Relat Cancer. 2014. PMID: 25287069 Free PMC article.

10

The novel estrogen 17alpha-20Z-21-[(4-amino)phenyl]-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diol induces apoptosis in prostate cancer cell lines at nanomolar concentrations in vitro.

Mobley JA, L'Esperance JO, Wu M, Friel CJ, Hanson RH, Ho SM. Mobley JA, et al. Among authors: ho sm. Mol Cancer Ther. 2004 May;3(5):587-95. Mol Cancer Ther. 2004. PMID: 15141016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters